Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: New evidence for imprinting of the Gsα gene

Giovanna Mantovani, Mohamad Maghnie, Giovanna Weber, Ernesto De Menis, Valeria Brunelli, Marco Cappa, Paola Loli, Paolo Beck-Peccoz, Anna Spada

Research output: Contribution to journalArticle


Heterozygous inactivating mutations in the Gsα gene cause Albright's hereditary osteodystrophy. Consistent with the observation that only maternally inherited mutations lead to resistance to hormone action [pseudohypoparathyroidism type Ia (PHP Ia)], recent studies provided evidence for a predominant maternal origin of Gsα transcripts in endocrine organs, such as thyroid, gonad, and pituitary. The aim of this study was to investigate the presence of pituitary resistance to hypothalamic hormones acting via Gsα-coupled receptors in patients with PHP Ia. Six of nine patients showed an impaired GH responsiveness to GHRH plus arginine, consistent with a complete GH deficiency (GH peak from 2.6-8.6 μg/liter, normal > 16.5), and partial (GH peak 13.9 and 13.6 μg/liter) and normal responses were found in two and one patient, respectively. Accordingly, IGF-I levels were below and in the low-normal range in seven and two patients. All patients had a normal cortisol response to 1 μg ACTH test, suggesting a normal corticotroph function that was confirmed by a normal ACTH and cortisol response to CRH test in three patients. In conclusion, we report that in addition to PTH and TSH resistance, patients with PHP Ia display variable degrees of GHRH resistance, consistent with Gsα imprinting in human pituitary.

Original languageEnglish
Pages (from-to)4070-4074
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Issue number9
Publication statusPublished - Sep 1 2003


ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this